Skip to the page

Data / Drug companies / Precision Dose, Inc.

Precision Dose, Inc.: 77 products in the FDA NDC directory, labeler code 68094

Precision Dose, Inc. (labeler code 68094) lists 77 products in the FDA National Drug Code Directory, covering 39 finished drugs by generic name. By type: 59 prescription drugs, 17 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 9, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68094
Products in commercial distribution
77
Packages
110
Finished drugs by generic name
39
Prescription products
59
Over the counter products
17
Controlled substance products
Schedule II 9, Schedule IV 7, Schedule V 2
Flagged as original packager
29 of 29 products that carry the flag
Started marketing in the last 12 months
4
Products with a marketing end date set
5
Earliest marketing start
April 13, 2004
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)6179.2%
Over the counter monograph drugs911.7%
New drug applications (NDA)67.8%
Drugs for further processing11.3%

Products by type

TypeProductsShare
Prescription drugs5976.6%
Over the counter drugs1722.1%
Drugs for further processing11.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Solution2026%
Suspension1823.4%
Tablet810.4%
Tablet, film coated79.1%
Tablet, coated67.8%
Capsule45.2%
Syrup33.9%
Injection, solution33.9%
Powder, for suspension22.6%
Tablet, extended release22.6%
Granule11.3%
Injection11.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Carbamazepine68094-225SuspensionGeneric drugs (ANDA)October 9, 2026
Carbamazepine68094-125SuspensionGeneric drugs (ANDA)October 9, 2026
Fosfomycin Tromethamine68094-064GranuleGeneric drugs (ANDA)February 15, 2026
Gabapentin68094-069Tablet, coatedGeneric drugs (ANDA)January 5, 2026
Lithium68094-077SolutionGeneric drugs (ANDA)October 24, 2025
Lacosamide68094-176SolutionGeneric drugs (ANDA)September 22, 2025
Lacosamide68094-076SolutionGeneric drugs (ANDA)September 22, 2025
Morphine Sulfate68094-556SolutionNew drug applications (NDA)September 1, 2025
Glycopyrrolate68094-073SolutionGeneric drugs (ANDA)July 7, 2025
Morphine Sulfate68094-156SolutionNew drug applications (NDA)June 6, 2025
Clobazam68094-074SuspensionGeneric drugs (ANDA)March 10, 2025
Sucralfate68094-041SuspensionGeneric drugs (ANDA)January 30, 2025
Acetaminophen68094-042SuspensionOver the counter monograph drugsJanuary 13, 2025
Lidocaine Hydrochloride68094-081SolutionGeneric drugs (ANDA)November 26, 2024
Levetiracetam68094-313Injection, solution, concentrateGeneric drugs (ANDA)October 10, 2024
Senna68094-049SyrupOver the counter monograph drugsJune 15, 2024
Cholestyramine68094-806Powder, for suspensionGeneric drugs (ANDA)April 25, 2024
Acetaminophen68094-075SuspensionDrugs for further processingApril 1, 2024
Famotidine68094-054Tablet, film coatedGeneric drugs (ANDA)March 28, 2024
Benzonatate68094-901CapsuleGeneric drugs (ANDA)March 1, 2024
Benzonatate68094-798CapsuleGeneric drugs (ANDA)March 1, 2024
Phentermine Hydrochloride68094-910CapsuleGeneric drugs (ANDA)February 15, 2024
Naltrexone Hydrochloride68094-909Tablet, film coatedGeneric drugs (ANDA)February 15, 2024
Metformin Hydrochloride68094-904Tablet, extended releaseGeneric drugs (ANDA)February 15, 2024
Azithromycin Dihydrate68094-900Tablet, film coatedGeneric drugs (ANDA)February 15, 2024

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.